IRVINE, Calif., May 21, 2018 /PRNewswire/ -- Inari Medical, Inc., announced today the FlowTriever System has received FDA 510(k) clearance for the treatment of pulmonary embolism ("PE"). This ...
According to the CDC, up to 600,000 Americans are diagnosed with deep vein thrombosis (DVT) or pulmonary embolisms (PE) each year. These blood clots kill between 60,000 and 100,000 people annually, ...
IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the ...
Irvine-based Inari Medical Inc., a commercial-stage medical device company whose products treat patients suffering from blood clots and other diseases affecting veins, says the impacts of COVID-19 ...
IRVINE, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from ...
Shares of Inari Medical Inc. established a new 52-week high after the company reported that preliminary revenue in Q4/20 increased year-over-year by greater than 140%. Commercial-stage medical device ...
Thrombolytics, intravenous or catheter-directed, can be an effective treatment option for acute pulmonary embolism (PE) but pose a hazard to the many patients who have risk factors for serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback